Table 2.
Baseline characteristics of subjects stratified by e-ALT1 and pRSW status n (%)
| Measurement (SD) | Total population (n = 996) | e-ALT: no; pRSW: no (n = 496) | e-ALT: no; pRSW: yes (n = 310) | e-ALT: yes; pRSW: no (n = 119) | e-ALT: yes; pRSW: yes (n = 71) | P value2 |
| Age (yr) | 32.1 (5.9) | 32.8 (6.0) | 30.9 (5.8) | 32.6 (5.3) | 31.4 (5.7) | 0.0001 |
| Body mass index (kg/m2) | 23.4 (2.9) | 23.2 (2.8) | 22.7 (2.8) | 25.0 (2.5) | 25.0 (3.0) | < 0.0001 |
| Waist (cm) | 78.3 (7.6) | 78.1 (7.4) | 76.4 (7.4) | 82.5 (6.3) | 81.3 (8.1) | < 0.0001 |
| Systolic blood pressure (mmHg) | 119.2 (14.1) | 118.2 (13.8) | 118.2 (14.3) | 123.0 (14.0) | 123.5 (14.1) | 0.0002 |
| Diastolic blood pressure (mmHg) | 72.9 (9.0) | 72.3 (8.6) | 72.3 (8.9) | 75.4 (10.0) | 75.7 (9.3) | 0.0002 |
| Fasting blood glucose (mg/dL) | 94.5 (14.8) | 95.2 (18.6) | 92.9 (8.1) | 95.1 (8.1) | 94.5 (15.2) | 0.1797 |
| Triglycerides (mg/dL) | 113.1 (86.3) | 109.3 (97.8) | 101.0 (55.6) | 149.3 (96.0) | 132.2 (74.7) | < 0.0001 |
| HDL cholesterol (mg/dL) | 48.6 (11.0) | 49.3 (10.9) | 49.6 (11.4) | 45.2 (10.8) | 44.9 (7.9) | < 0.0001 |
| Alanine aminotransferase (U/L) | 31.0 (29.4) | 21.7 (7.7) | 21.1 (8.4) | 68.8 (42.6) | 75.8 (54.3) | < 0.0001 |
| Aspartate aminotransferase (U/L) | 25.8 (17.9) | 21.9 (5.1) | 21.8 (5.5) | 39.3 (23.3) | 48.5 (47.8) | < 0.0001 |
| Insulin (mg/dL) | 8.5 (6.2) | 8.0 (4.9) | 7.4 (5.2) | 11.4 (7.8) | 11.6 (11.4) | < 0.0001 |
1
ALT > 40 mg/dL;
2
ANOVA was conducted, using Tukey’s test.